The National Association of Managed Care Physicians' Value Based Care Council says its newly-developed short form streamlines how value propositions are shared between key stakeholders. "[The Product Value Proposition Customer Engagement Short Form] provides a concise and consistent manner with […]
Paper Looks at Impact of Coverage Policies on Pharma Incentives
A recently-published study by Leila Agha, Soomi Kim and Danielle Li analyzes how insurance coverage policies impact incentives for innovation in the pharmaceutical industry. The study suggests the decision by pharmacy benefit managers in 2012 to adopt "closed formularies" resulted in some […]
Article: Drug Pricing Back in Spotlight
With the race for COVID-19 treatments and a vaccine well under way, the issue of drug pricing is again front and center, BioPharm International reports. As uncertainty swirls around Pfizer and AstraZeneca's pledge to offer COVID-19 treatments at no profit, according to the report, some […]
MAPS Appoints Pracyk as President
The Medical Affairs Professional Society (MAPS) appointed its new president of the Americas region, John Pracyk. MAPS in an announcement says Pracyk "brings to the MAPS organization a wealth of experience." "We are honored to include John in this highly visible leadership role, where he is […]
ICER Posts Evidence Report on Obeticholic Acid for NASH
The Institute for Clinical and Economic Review (ICER) on Monday, July 21, posted an evidence report on Intercept Pharmaceuticals' obeticholic acid (OCA) for the treatment of nonalcoholic steatohepatitis (NASH). ICER CMO David Rind in a statement said the review concluded there was much […]
Article Spotlights Virtual Component of ADAPTABLE Study
A recent Clinical Leader article spotlights how the ADAPTABLE study, which was launched in 2016 by PCORI and the Duke Clinical Research Institute, included virtual visits with patients. "We liked the idea of approaching patients to participate in research studies where they live instead of […]
IQVIA’s Dreyer Stresses Importance of RWE Amid Pandemic
In a recent interview with Managed Healthcare Executive, IQVIA CSO Nancy Dreyer said the COVID-19 pandemic has made the use of real-world evidence all the more urgent. Dreyer said the idea of using RWE to create a common external control arm is "one of the biggest opportunities we can't […]
Report Spotlights NPC’s Webinar on COVID-19 Prices
A recent report by The Pink Sheet spotlights the National Pharmaceutical Council's (NPC) recent meeting on COVID-19 drug prices. The webinar was held July 14, and included insights from: Peter B. Bach, MD, MAPP, Director, Center for Health Policy and Outcomes, Memorial Sloan Kettering Cancer […]
NPC Spotlights New NPC/Duke-Margolis Health Policy Fellow Salama Freed
A recent National Pharmaceutical Council blog post spotlights Salama Freed, the new NPC/Duke-Margolis Postdoctoral Health Policy fellow. Freed says she believes the fellowship will help bolster her understanding of health policy. "I want this research to actually turn into something," she […]
Roche, Genentech Enter into RWD Deal with PicnicHealth
Roche and Genentech have entered into an agreement with PicnicHealth, a San Francisco-based startup, to generate new insights into certain diseases, according to a MobiHealthNews report. According to the report, the agreement will initially focus on multiple sclerosis, but could in the future […]
Aetion, Cegedim Partnership Looks to Bring Together RWD, Clinical Trial Tech
A new partnership between Aetion and Cegedim Health Data looks to integrate real-world data compiled from European sources into clinical trial technology, Outsourcing Pharma reports. The collaboration involves Cegedim's The Health Improvement Network (THIN) database and the Aetion Evidence […]
Blog Post: ‘Diverse Initiatives’ Necessary to Bolster Condition-Based Payment Models
While condition-based payment models have the potential to facilitate "specialist-driven value-based care," a number of key hurdles remain, the authors of a recent Health Affairs Blog post write. "Diverse initiatives will be needed in the coming years to expand new model designs to a wider range […]
First Installment in ICER Webinar Series is Friday
The first session of the Institute for Clinical and Economic Review's (ICER) upcoming webinar series is set for Friday, July 24. ICER is hosting a 3-part colloquium series to complement its recent white paper on alternative approaches for pricing COVID-19 treatments and vaccines. The first […]
MAPS, phactMI Partner on New Medical Information Working Group
The Medical Affairs Professional Society (MAPS) and phactMI are partnering on a new medical information working group. According to MAPS, the Medical Information Focus Area Working Group (FAWG) will focus on "leveraging the expertise and experience of the global medical information […]
Elligo Launches Expanded SOAR Model
Elligo Health Research announced the launch of its expanded System of Accelerated Research (SOAR) model for decentralized and hybrid trial models. According to a press release, the platform offers full remote monitoring. "We are extremely excited to launch our tech-enabled solution created to […]
Companies Ramping Up Digital Transformation Plans as Result of COVID-19, Survey Finds
A recent survey by Twilio suggests that a clear majority of companies have sped up their digital transformation plans in response to the COVID-19 pandemic. "Decade-long digital transformation roadmaps got compressed into days and weeks in order to respond to the realities of shelter in place," […]
Gao: ‘Misunderstanding of P-values Spells Disaster’
A greater understanding of the p-value could go a long way in trying to combat contradictory health advice, Jian Gao with the Department of Veterans Affairs writes in a post on The Incidental Economist. Gao writes that the tool which is generally used as a safeguard against randomness "has been […]
Impact of Drug Cost Transparency
In the latest installment of the Relentless Health Value podcast, RxRevu CEO and Co-Founder Carm Huntress discusses how greater transparency in drug prices could impact stakeholders, including patients. Surescripts' new real-time drug price transparency solution, for example, is one tool that […]
Zemcik, Fry Spotlight CMS Best Price Proposal
Commercial Solutions' Rick Fry and TrialCard's Jason Zemcik spotlight the Centers for Medicare and Medicaid Services' best price proposal in a recent Drug Channels post. "This Proposed Rule is sure to generate significant discussion on both sides of the issue," they write. "How CMS will […]
Research Suggests Pharma Retains Lowest Share of Revenue than Other High R&D Industries
Oxford Economics in a new study suggests the pharmaceutical industry only retains 52 percent of total spending, with the remaining amount going to wholesalers, distributors and retail margins, according to a PhRMA blog post. Other key industries with a heavy emphasis on research and development […]
MSLS Webinar to Highlight Board Certification Program
The Medical Science Liaison Society (MSLS) is set to host a free webinar on the benefits of taking the MSL-Board Certification exam. The event is set for 1 p.m. EST July 28. Featured speakers for the event are Syneos Health's Larry Dollar and Sunovion Pharmaceuticals' Jihad Rizkallah. For […]
Raman Offers Primer on U.S. Health System in New Book
Sivakumaran Raman in his latest book offers an overview of the U.S. health care system. "Just Enough Healthcare: A pick-up-and-read-through primer on the US healthcare system" covers a range of topics, including health systems and providers, insurance and payers. To learn more about this book […]
Taking Action from RWE Analytics: Use of Health Insights Dataset Reveal Underdiagnosis and Care Gaps in NASH and NAFLD
Excerpt of tHEORetically Speaking blog post sponsored by Veradigm Nonalcoholic fatty liver disease (NAFLD), including the more aggressive NASH (nonalcoholic steatohepatitis), has become a major public health concern, affecting about one in four Americans (Younossi 2018). Its increasing prevalence […]
ISPOR Seeks New Members for Health Science Policy Council
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is searching for three mid-career members for its Health Science Policy Council (HSPC). HSPC advises the ISPOR Board of Directors on research issues in health economics and outcomes research. The terms will last […]
On-Demand Webinar Offers Guidance for Getting Started in MedComms
A recent webinar hosted by NetworkPharma.tv offers guidance for individuals interested in entering a career in the medical communications landscape. The on-demand webinar is available to watch on YouTube. Featured speakers include: Linda Harrison, author of "Evidence generation and […]
Rubenstein Talks Modern RWD, RWE in Regulatory Decision-Making
FDA Center for Devices and Radiological Health Director of Personalized Medicine Wendy Rubenstein says modern sources of real-world evidence and data "are of a progressively higher quality," BioWorld reports. According to the report, Rubenstein made the comments during a recent webinar hosted by […]
FDA Rejects Intercept’s OCA for NASH
The Food and Drug Administration (FDA) last month rejected Intercept Pharmaceuticals' nonalcoholic steatohepatitis (NASH) drug, creating a major delay in the drugmaker's approval roadmap, BioPharma Dive reports. According to the report, Intercept says the FDA decided the benefits of obeticholic […]
Opinion: Discuss Price for COVID-19 Vaccine Now, Not Later
The U.S. should begin pricing discussions for a COVID-19 vaccine before we get "stuck paying dearly for shots that the rest of the world will get much cheaper," the author of a recent opinion piece published in The New York Times writes. Elisabeth Rosenthal, author and editor and chief of Kaiser […]
Report Explores Patient Centricity in Clinical Trials
A new report by the Economist Intelligence Unit explores the importance of expanding patient engagement in the clinical trial landscape. The report, which was sponsored by Medidata, features insights experts including: Jennifer Byrne, Javara CEO; Luther Clark, Merck deputy chief patient […]
Article: Researchers Point to Germany’s Model for Purchasing Cancer Drugs
Researchers say U.S. policymakers should look to Germany's drug purchasing model to try and better align cancer drug prices with their clinical benefits, according to a STAT Pharmalot article. According to the article, Germany's model ultimately led to a 25 percent drop in prices one year […]
